Five9, Inc.

Five9, Inc. Q2 FY2025 earnings

FIVN

Quarter ended Jun 2025.

← Q1 FY2025Q3 FY2025 →
Revenue
$283.3M
+12.4% YoY
Gross margin
54.9%
+1.8 pp YoY
Operating margin
-0.6%
+7.1 pp YoY
Net income
$1.2M
+109.0% YoY

Summary

Five9 reported record second-quarter revenue of $283.27 million, up 12.4% from the prior-year quarter. Gross profit rose 16.3% to $155.40 million. Gross margin expanded to 54.9% from 53.0%. Operating loss narrowed to $1.56 million from $19.36 million. Operating margin improved to -0.6% from -7.7%. Net income was $1.15 million, compared with a net loss of $12.82 million a year earlier. Diluted EPS was $0.01 versus a loss of $0.17. For the first six months, revenue was $562.97 million, up 12.8%. Gross profit was $309.14 million, up 16.2%. Gross margin was 54.9% versus 53.3%. Operating loss narrowed to $6.99 million from $40.06 million. Operating margin was -1.2% versus -8.0%. Net income was $1.73 million versus a net loss of $19.89 million. Diluted EPS was $0.02 versus a loss of $0.27.

Cash generation improved. Second-quarter operating cash flow was $35.06 million, up 76.4% from $19.88 million. Year-to-date operating cash flow was $83.44 million, up 59.8% from $52.23 million. Capital expenditures fell to $3.49 million from $6.77 million in the quarter. For the first six months, capital expenditures were $8.22 million, down 56.1% from $18.72 million. Deferred revenue was $68.01 million, up 4.2%. Remaining performance obligations were $1.15 billion, up 9.8%. The annual dollar-based retention rate was 108%, flat year over year. Subscription revenue grew 16% year over year. Enterprise AI revenue grew 42% year over year and represented 10% of Enterprise subscription revenue. Enterprise AI bookings more than tripled year over year.

Non-GAAP results also improved. Adjusted gross margin was 63.0% versus 60.5%. Non-GAAP net income was $58.3 million, or $0.76 per diluted share, compared with $38.9 million, or $0.52 per diluted share. Non-GAAP operating income was $54.5 million versus $31.0 million. Adjusted EBITDA was $67.9 million, or 24.0% of revenue, compared with $41.8 million, or 16.6% of revenue. Management said the quarter set a Q2 record for both operating and free cash flow.

Guidance points to continued growth. For the third quarter of 2025, Five9 expects revenue of $283.0 million to $286.0 million. Non-GAAP net income per share is guided to $0.72 to $0.74. For the full year 2025, revenue is guided to $1.1435 billion to $1.1495 billion. Non-GAAP net income per share is guided to $2.86 to $2.90. The company assumes diluted shares of approximately 87.5 million for third-quarter GAAP EPS, 78.1 million for third-quarter non-GAAP EPS, 88.5 million for full-year GAAP EPS, and 77.7 million for full-year non-GAAP EPS.

Cost actions and risks remain in focus. The 2025 reduction in force plan cut global full-time employees by approximately 4%. Five9 incurred $7.8 million in restructuring costs under that plan in the second quarter and first six months, plus $2.1 million in stock-based compensation. The 2024 plan reduced employees by approximately 6% and cost $9.6 million in 2024. As of June 30, 2025, the company had $692.6 million in working capital, including $205.5 million in cash and cash equivalents and $430.4 million in marketable investments. The 2025 convertible notes matured on June 1, 2025, and Five9 settled them with a $434.4 million cash payment. The 2029 convertible notes had $747.5 million in principal outstanding as of June 30, 2025. Management expects macroeconomic challenges, global tariff increases, the Russia-Ukraine conflict, and Middle East conflicts to keep pressuring revenue. The company also faces a securities class action filed on December 4, 2024, an amended complaint filed on May 30, 2025, and a motion to dismiss filed on July 29, 2025. A related derivative action is stayed. Five9 appointed Bryan Lee as chief financial officer effective July 31, 2025.

Forecast

Management guidance
ReportedGuidance

Guided revenue, Q3 FY2025$283.0M – $286.0M
Midpoint$284.5M
Growth vs Q2 FY2025+0.4%
Growth vs Q3 FY2024+7.7%
Q3 2025
GAAP net income per share$0.06 to $0.12
Non-GAAP net income per share$0.72 to $0.74
Full Year 2025
Revenue$1.1435 to $1.1495 billion
GAAP net income per share$0.23 to $0.30
Non-GAAP net income per share$2.86 to $2.90

Reported figures

GAAP, from SEC filings
MetricQ2 FY2025Q1 FY2025QoQQ2 FY2024YoY
Revenue$283.3M$279.7M+1.3%$252.1M+12.4%
Gross profit$155.4M$153.7M+1.1%$133.7M+16.3%
Gross margin54.9%55.0%-0.1 pp53.0%+1.8 pp
Research & development$39.9M$41.1M-2.9%$40.7M-2.0%
Sales & marketing$80.7M$82.9M-2.6%$78.3M+3.0%
General & administrative$36.4M$35.2M+3.4%$34.0M+7.1%
Total operating expenses$157.0M$159.2M-1.4%$153.0M+2.6%
Operating income (loss)-$1.6M-$5.4M+71.2%-$19.4M+91.9%
Operating margin-0.6%-1.9%+1.4 pp-7.7%+7.1 pp
Net income (loss)$1.2M$576.0K+100.3%-$12.8M+109.0%
Net margin0.4%0.2%+0.2 pp-5.1%+5.5 pp
Diluted EPS$0.01$0.01±$0.00-$0.17+$0.18
Customers3,0003,000±0.0%——

Risks

HIGHMacroeconomic

MD&A states the company expects macroeconomic challenges to continue to have an adverse impact on revenue in future periods, citing global tariff increases, the Russia-Ukraine conflict, and conflicts in the Middle East. It also says the installed base business continues to experience macroeconomic challenges despite increases in up-sells and cross-sells.

HIGHLitigation

A putative securities class action filed December 4, 2024 against the company, its CEO, and its CFO remains pending; an amended complaint was filed May 30, 2025, and the company filed a motion to dismiss on July 29, 2025. A related shareholder derivative action is stayed, and the company cannot estimate the reasonably possible loss or range of losses.

MEDIUMSales Cycle

Annual Dollar-Based Retention Rate was 108% for the twelve months ended June 30, 2025, flat versus 108% for the twelve months ended June 30, 2024. MD&A attributes the flat rate to continued macroeconomic headwinds, seasonal decreases in consumer and healthcare vertical markets, and a single large new customer ramping throughout 2024, offset by AI momentum and expansions of larger existing customers.

MEDIUMTalent Retention

The 2025 Plan reduced global full-time employees by approximately 4% and incurred $7.8 million in restructuring costs plus $2.1 million in additional stock-based compensation during the three and six months ended June 30, 2025. The company is prioritizing investments in key strategic areas, including artificial intelligence, which may create execution and retention risk.

MEDIUMLiquidity

The 2025 convertible senior notes matured on June 1, 2025 and were settled with a $434.4 million cash payment, reducing cash and investments. As of June 30, 2025, $747.5 million aggregate principal of 2029 convertible senior notes remains outstanding, and interest expense increased 23% for the six months ended June 30, 2025 compared to the prior-year period.

Annual Dollar-Based Retention Rate (TTM)
108%
Total Customers
more than 3,000
Adjusted EBITDA
$67.9 million
Adjusted EBITDA Margin
24.0%
Adjusted Gross Margin
63.0%
Non-GAAP Operating Income
$54,454 thousand
Non-GAAP Net Income
$58.3 million
Non-GAAP Net Income per Diluted Share
$0.76
Non-GAAP Net Income Margin
20.6%
Enterprise AI Revenue Growth
42%
Subscription Revenue Growth
16%
Enterprise AI Revenue as % of Enterprise Subscription Revenue
10%
Subscription and Related Usage Revenue as % of Total Revenue
93%

Adjusted EBITDA

22 quarters
$67.9M
Q2 FY2025+28.8%

Adjusted EBITDA Margin

19 quarters
24.0%
Q2 FY2025+0.9pp

Adjusted Gross Margin

18 quarters
63.0%
Q2 FY2025-0.5pp

Total Customers

12 quarters
~3,000
Q2 FY2025+0.0%

Non-GAAP Operating Income

10 quarters
$54.5M
Q2 FY2025+10.0%

Enterprise AI Revenue Growth

4 quarters
42%
Q2 FY2025-4.0pp

Non-GAAP Net Income

4 quarters
$58.3M
Q2 FY2025+63.3%

Non-GAAP Net Income Margin

4 quarters
20.6%
Q2 FY2025+6.1pp

Subscription Revenue Growth

4 quarters
16%
Q2 FY2025-3.0pp

Summary, forecast, risks and KPIs are extracted from Five9, Inc.'s SEC filings for Q2 FY2025 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 1, 2026.